Clinical Trial Update: Open-Label Study of 18F-mFBG for Imaging Neuroblastoma [Phase 3]

View source ↗

Summary

Open-label Phase 3 trial evaluating 18F-mFBG for imaging neuroblastoma is active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• [18F]-MFBG (18F-MFBG)

Snippet

Sponsor: Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) | Conditions: Neuroblastoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING